Rexford Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Rexford Capital's AZN Position: Q3 2026 in Review
Rexford Capital reduced its AstraZeneca (AZN) stake by 6.9% in Q3 2026, selling an estimated $77.8K and leaving 6,268 shares worth $1.01M. The position accounts for 0.63% of the portfolio, ranked #46.
Rexford Capital first reported a position in AZN in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.33M in Q1 2026. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Rexford Capital held 6,268 shares of AstraZeneca worth $1.01M as of Q3 2026.
- Rexford Capital sold 467 AstraZeneca shares in Q3 2026, an estimated $77.8K.
- AstraZeneca made up 0.63% of Rexford Capital's portfolio in Q3 2026, its #46 holding.
- Rexford Capital first reported a position in AstraZeneca in Q2 2025 and has held it in 6 quarters since.
- Rexford Capital's AstraZeneca position peaked at $1.33M in Q1 2026.
- 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Rexford Capital's 13F filing for Q3 2026, filed 13 Nov 2026.